Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

SpotDraft’s software includes AI-assisted redlining tools, which is the process of editing a contract where two or more ...

Yet only “Gray Tree” has scale-invariant branch diameters. When Mondrian removes the scale invariance in “Blooming Apple Tree ...

Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

Google also released an experimental version of Gemini 2.0 Pro, the company’s flagship model with the best performance for ...

HAPPY BIRTHDAY — to David Edelman, Ropes & Gray’s Abby Cable; former Gov. Charlie Baker senior adviser and the NCAA’s Tim ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

On Thursday, Jan. 30, The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill from Vertex Pharmaceuticals called suzetrigine, which is being sold under ...